EP3856341
Kristallað form af (S)-1-(4-flúorófenýl)-1-(2-(4-(6-(1-metýl-1h-pýrasól-4-ýl)pyrróló[2,1-f][1,2,4]tríasín-4-ýl)píperasínýl)-pýrimídín-5-ýl)etan-1-amín og aðferðir við gerð þess
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.4.2020EP published:
6.9.2023EP application number:
20722936.0
EP translation filed:
29.11.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
9.4.2040Expiry date:
9.4.2026Next due date:
30.4.2026
Title in English:
CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)PIPERAZINYL)-PYRIMIDIN-5-YL)ETHAN-1-AMINE AND METHODS OF MAKINGLanguage of the patent:
English
Timeline
Today
10.4.2020EP application
6.9.2023EP Publication
29.11.2023Translation submitted
15.1.2024Registration published
9.4.2026Expires
Owner
Name:
Blueprint Medicines CorporationAddress:
45 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
WAETZIG, Joshua, D.Address:
Cambridge, MA 02139, US
Name:
MAR, BrentonAddress:
Cambridge, MA 02139, US
Name:
HEINRICH, BrianAddress:
Cambridge, MA 02139, US
Name:
WILKIE, GordonAddress:
Cambridge, MA 02139, US
Name:
MACEACHERN, LaurenAddress:
Dartmouth, Nova Scotia, B2Y4C3, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962833527 PDate:
12.4.2019Country:
US
Number:
201962844575 PDate:
7.5.2019Country:
US
Number:
202062990269 PDate:
16.3.2020Country:
US
Classification
Categories:
A61P 17/00, A61P 35/00, A61P 35/02, C07D 487/04, A61K 31/519
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 2.5.2024
Expires: 9.4.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 14.3.2025
Expires: 9.4.2026
Payer: Árnason Faktor ehf.